Amantadine

Amantadine

SCHEMBL572799

NC12CC3CC(CC(C3)C1)C2.O

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BM

The experimentally established mechanism targets of Amantadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 known ✓ Q05586 6/20 0.93
GRIN2A known ✓ Q12879 6/20 0.93
GRIN2D known ✓ O15399 5/20 0.93
GRIN3B known ✓ O60391 5/20 0.93
GRIN2B known ✓ Q13224 5/20 0.93
GRIN2C known ✓ Q14957 5/20 0.93
GRIN3A known ✓ Q8TCU5 5/20 0.93
LMNA P02545 4/20 0.93
SLC22A1 O15245 2/20 0.93
NFKB1 P19838 2/20 0.93
SLC22A2 O15244 2/20 0.93
SLC47A1 Q96FL8 2/20 0.93
TSHR P16473 1/20 0.93
STAT6 P42226 1/20 0.93
SIGMAR1 Q99720 1/20 0.93
THRB P10828 2/20 0.87
PMP22 Q01453 2/20 0.87
POLB P06746 1/20 0.87
BLM P54132 1/20 0.87
SMN1; SMN2 Q16637 1/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amantadine SCHEMBL28046544 1.00 GRIN1 (0.93) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL28246033 0.97 GRIN1 (0.87) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL20409394 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL21310017 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL4098 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL15532073 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL3642447 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL21309814 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL15672299 0.96 GRIN1 (1.00) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Amantadine SCHEMBL23859927 0.93 GRIN1 (0.93) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120041847-A Method for electrochemical synthesis of hexamethylenediamine from acrylonitrile 万华化学集团股份有限公司 2025-05-27 CN claimed
CN-118667138-A Long-chain alkyl polycarbonate, synthesis method thereof and polycarbonate fiber 浙江理工大学 2024-09-20 CN claimed
CN-118291998-A Method for electrochemical co-production of adiponitrile and furoic acid 万华化学集团股份有限公司 2024-07-05 CN claimed
CN-117185315-B Method for preparing Cu-SSZ-39 molecular sieve 天津派森新材料技术有限责任公司 2024-06-18 CN claimed
CN-118165221-A Allophanate composition, polyisocyanate composition, and preparation methods and applications thereof 万华化学(宁波)有限公司 2024-06-11 CN claimed
US-11883804-B2 Method of making SSZ-13 zeolites with high acidity and low silica to alumina ratio (SAR) PACIFIC INDUSTRIAL DEVELOPMENT CORPORATION (US) 2024-01-30 US claimed
CN-112912340-B Process for preparing SSZ-13 zeolite with high acidity and low silica to alumina ratio (SAR) 太平洋工业发展公司 2024-01-02 CN claimed
CN-117185315-A Method for preparing Cu-SSZ-39 molecular sieve 天津派森新材料技术有限责任公司 2023-12-08 CN claimed
CN-114713041-B Method for preparing Si-CHA molecular sieve membrane in situ 南京工业大学 2023-09-29 CN claimed
CN-113716585-B Method for preparing Cu-SSZ-13 molecular sieve by one-step method 天津派森新材料技术有限责任公司 2023-06-13 CN claimed
CN-107511170-A The preparation method of the molecular sieve catalyst of binderless ZSM-5 5 中国石油化工股份有限公司 2017-12-26 CN claimed
CN-107511165-A The preparation method of binder free mercerising molecular sieve catalyst 中国石油化工股份有限公司 2017-12-26 CN claimed
CN-107511169-A The molecular sieve catalysts of ZSM 5, preparation method and application 中国石油化工股份有限公司 2017-12-26 CN claimed
CN-107511163-A Molecular sieve catalyst, preparation method and application 中国石油化工股份有限公司 2017-12-26 CN claimed
CN-107511164-A Y molecular sieve catalyst, preparation method and application 中国石油化工股份有限公司 2017-12-26 CN claimed
CN-107497482-A A kind of preparation and application of new type low temperature composite catalyst 廊坊市北辰创业树脂材料有限公司 2017-12-22 CN claimed
CN-104803397-B MCM-49 molecular sieve with low silica-alumina ratio, and preparation method thereof 中国石油化工股份有限公司 2017-03-22 CN claimed
CN-106315610-A Method for synthesizing CHA molecular sieve through ultrasonic pretreatment of coal gangue 天津大学 2017-01-11 CN claimed
US-20160297782-A1 CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) 2016-10-13 US claimed
WO-2016164585-A1 IMPROVED CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION LYONDELL CHEMICAL TECHNOLOGY, L.P. (US) 2016-10-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297782-A1 CATALYST PERFORMANCE IN PROPYLENE EPOXIDATION AOC2, AOC3, AOX1 GRIN1 3906/4885GRIN2A 4121/4885GRIN2D 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.